News

Insulet's Q2 Beat Is Impressive, But The Elevated Valuation Makes The Stock A Hold

Insulet (PODD) excels with strong Q2 results, Omnipod 5 app launch, and >20% growth outlook. Read here for an investment ...
StockStory.org on MSN16h

Sotera Health Company, Incyte, Exact Sciences, Bausch + Lomb, and Addus HomeCare Shares Skyrocket, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation ...
StockStory.org on MSN16h

Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation ...
StockStory.org on MSN16h

Penumbra, STAAR Surgical, CONMED, Acadia Healthcare, and Select Medical Shares Are Soaring, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation ...

Ondas slides after pricing $150M stock offering

Ondas (ONDS) priced a public offering of 46.16 million shares at $3.25 each, aiming to raise $150 million before expenses.
StockStory.org on MSN1d

C3.ai, Health Catalyst, Wix, Jamf, and ON24 Shares Are Soaring, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after cooler-than-expected inflation data ignited investor ...
StockStory.org on MSN1d

Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know

What Happened? A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report ...
InvestorsHub on MSN2d

Nyxoah Shares Climb Following FDA Clearance of Genio Device for Sleep Apnea Treatment

Nyxoah SA (NASDAQ:NYXH) saw its stock rise 9.4% after the FDA granted approval for its Genio system designed to treat moderate to severe obstructive sleep apnea (OSA). The Belgium-based medtech firm ...
The Manila Times6d

Omada Health Reports Second Quarter 2025 Results

Revenue of $61 million, up 49%52%Member Growth and Significant Progress Toward Profitability SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) --  Omada Health, Inc. (Nasdaq: OMDA), the virtual ...